- Price
- $266.42
- Day
- -1.12%
- Mkt Cap
- $43.85B
- 52W Range
- $154.50 – $273.88
- Volume
- 5.59M
- Beta
- 1.19
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
IQV's accelerating organic growth, robust R&DS bookings and expanding AI adoption are strengthening demand visibility and business momentum.
Read full article
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article
Arizona State Retirement System lifted its stake in IQVIA Holdings Inc. (NYSE: IQV) by 5.1% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 48,655 shares of the medical research company's stock after purchasing an additional 2,372 shares during the quarter. Arizona
Read full article
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $2,000,000,000 through an offering of senior notes due 2034 (the “Notes”). The proceeds from the Notes offering will be used to redeem in full the Issuer's Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer's revolving credit facility and to pay fees and expenses relate.
Read full article
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2034 (the “Notes”). The proceeds from the Notes offering will be used to redeem in full the Issuer's Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer's revolving credit facility and to pay fees and e.
Read full article
IQVIA Holdings Inc. (âIQVIAâ) (NYSE: IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the âIssuerâ), intends to raise $2,000,000,000 th
Read full article
B. Metzler seel. Sohn and Co. AG cut its holdings in IQVIA Holdings Inc. (NYSE: IQV) by 28.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 24,610 shares of the medical research company's stock after selling 9,713 shares
Read full article
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster. Traditional approaches in clinical development no longer keep pace with increasing trial complexity. IQVIA Predictive Clinical.
Read full article